Fuller & Thaler Asset Management Inc. Reduces Stake in HealthEquity, Inc. $HQY

Key Points

• Fuller & Thaler Asset Management Inc. drastically decreased its stake in HealthEquity, Inc. by 99.8%, holding only 757 shares after selling over 501,000 shares in the first quarter, with current holdings valued at approximately $67,000.
• Several large investors, including Invesco Ltd. and T. Rowe Price, have significantly increased their stakes in HealthEquity during the same period, indicating a trend of institutional investment in the company.
• Analysts have raised price targets for HealthEquity, with a consensus target price now set at $118.55, suggesting optimism about the company's future performance.

Fuller & Thaler Asset Management Inc. decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 99.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 757 shares of the company's stock after selling 501,815 shares during the period. Fuller & Thaler Asset Management Inc.'s holdings in HealthEquity were worth $67,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Transce3nd LLC bought a new position in HealthEquity during the 4th quarter valued at approximately $29,000. Versant Capital Management Inc bought a new position in shares of HealthEquity in the 1st quarter worth approximately $28,000. Larson Financial Group LLC raised its position in shares of HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after acquiring an additional 642 shares in the last quarter. Whipplewood Advisors LLC raised its position in shares of HealthEquity by 5,060.0% in the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after acquiring an additional 759 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in shares of HealthEquity by 104.8% in the 1st quarter. UMB Bank n.a. now owns 848 shares of the company's stock worth $75,000 after buying an additional 434 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. The trade was a 3.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president directly owned 75,689 shares in the company, valued at $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 291,744 shares of company stock valued at $32,705,007. 1.50% of the stock is currently owned by insiders.

HealthEquity Price Performance

NASDAQ:HQY traded down $2.40 on Monday, reaching $87.42. 905,205 shares of the company's stock traded hands, compared to its average volume of 1,008,071. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a 50-day simple moving average of $96.78 and a 200-day simple moving average of $96.43. The firm has a market cap of $7.56 billion, a PE ratio of 63.81, a P/E/G ratio of 1.39 and a beta of 0.54. HealthEquity, Inc. has a 12 month low of $73.84 and a 12 month high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The business had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.During the same period last year, the firm earned $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have commented on HQY shares. Deutsche Bank Aktiengesellschaft increased their target price on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. JMP Securities increased their target price on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research note on Wednesday, June 4th. Bank of America increased their target price on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research note on Wednesday, June 4th. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Finally, Barrington Research raised their target price on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $118.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.